Dr. Pragya Dhaubhadel, MD

Dr. Dhaubhadel practices at Geisinger Community Medical Center in Scranton, Pennsylvania, part of Risant Health.

Dr. Dhaubhadel's NPI, 1639442528, was assigned on February 23, 2012. Dr. Dhaubhadel holds Pennsylvania license MD456394.

Dr. Dhaubhadel's primary practice is Geisinger Community Medical Center, at 1822 Mulberry Street, Scranton, PA 18510 in Lackawanna County. The practice phone is (570) 703-8000. Dr. Dhaubhadel also practices at Geisinger Community Medical Center, 1800 Mulberry St, Scranton, PA 18510.

Dr. Dhaubhadel's primary practice is Geisinger Community Medical Center in Scranton, Pennsylvania, part of Risant Health. Dr. Dhaubhadel is also affiliated with Geisinger Wyoming Valley Medical Center. The medical group on file is Geisinger.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dhaubhadel practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Dhaubhadel's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Dhaubhadel is licensed in Pennsylvania.

CMS data shows 594 Medicare services from Dr. Dhaubhadel across 8 procedure codes in 2024, for 310 Medicare patients. Medicare paid $50,808 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 310 Medicare patients who saw Dr. Dhaubhadel in 2024. The largest group is 75 to 84, with 102 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dhaubhadel's median patient age at 70, with 42% women.

In 2024, Dr. Dhaubhadel wrote 238 Medicare Part D claims for 51 patients. 84% of them were for generic drugs. CMS names the drug for 137 of them, across 8 drugs with 11 or more claims each, at $62,372 in total drug cost. In 2023, CMS named 91 claims across 5 drugs.

Dr. Dhaubhadel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dhaubhadel as offering telehealth.

Dmand AI links 3 papers to Dr. Dhaubhadel, published from 2021 to 2025. Dr. Dhaubhadel's most frequent co-authors are Kathleen O'Neil Degnan, MD, Daniel J. Diekema, MD and Marci Lynn Drees, MD.

CMS Open Payments shows 5 general payments to Dr. Dhaubhadel from 3 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $282.